BMS-986482 / BMS - LARVOL DELTA

CA2360001: A Phase 1/2 Study of BMS-986482 Alone or Combination Therapy in Participants with Advanced Solid Tumors (clinicaltrialsregister.eu) - P1/2 | N=62 | Recruiting | Sponsor: Bristol-Myers Squibb Services Unlimited Company

Monotherapy • New P1/2 trial • Breast Cancer • Colorectal Cancer • Lung Cancer • Melanoma • Non Small Cell Lung Cancer • Oncology • Solid Tumor

CA236-0001: A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors (clinicaltrials.gov) - P1/2 | N=413 | Recruiting | Sponsor: Bristol-Myers Squibb | Not yet recruiting ➔ Recruiting

Enrollment open • Oncology • Solid Tumor